Boris Breiner

Title: Boris Breiner: A Pioneer in Microfluidics

Introduction

Boris Breiner, a renowned inventor based in Cambridge, GB, has made significant contributions to the field of microfluidics with a notable portfolio of nine patents. His innovative work focuses on the sequencing of polynucleotides, which has valuable applications in genomics and molecular biology.

Latest Patents

Breiner's latest patents include a cutting-edge microfluidic device designed for characterizing polynucleotides. This device utilizes a stream of microdroplets, some containing a single nucleotide base, which undergo reaction with a capture system to detect ordered sequences of nucleotide bases through progressive pyrophosphorolysis. Additionally, his patent on a single nucleotide detection method outlines a systematic approach to determining the sequence of nucleotide bases in a polynucleotide analyte. This method encompasses generating a stream of single nucleotide bases, producing captured molecules, releasing detectable elements, and ultimately determining the sequence of nucleotide bases.

Career Highlights

Over the years, Boris Breiner has worked with several prestigious organizations, including Base4 Innovation Limited and Florida State University Research Foundation, Inc. His role in these companies has contributed to advancements in the field of microfluidic technology and its applications.

Collaborations

Breiner has collaborated with notable individuals in the sector, including Cameron Alexander Frayling and Barnaby Balmforth. These partnerships have fostered innovation and research, establishing a collaborative environment that enhances the development of pioneering technologies.

Conclusion

Boris Breiner stands out as a key figure in the realm of microfluidic innovations. With his extensive patent portfolio and impactful collaborations, he continues to push the boundaries of knowledge and technology in the sequencing of polynucleotides, making significant strides in scientific research and applications.